Geode Capital Management’s Tonix Pharmaceuticals TNXP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.31M | Buy |
|
|||||
|
2025
Q1 | $1.11M | Buy |
|
|||||
|
2024
Q4 | $650K | Buy |
|
|||||
|
2024
Q3 | $17.2K | Buy |
|
|||||
|
2024
Q2 | $11.5K | Buy |
|
|||||
|
2024
Q1 | $74.2K | Buy |
|
|||||
|
2023
Q4 | $43K | Sell |
|
|||||
|
2023
Q3 | $68.8K | Buy |
|
|||||
|
2023
Q2 | $135K | Hold |
|
|||||
|
2023
Q1 | $315K | Buy |
|
|||||
|
2022
Q4 | $144K | Buy |
|
|||||
|
2022
Q3 | $183K | Buy |
|
|||||
|
2022
Q2 | $209K | Sell |
|
|||||
|
2022
Q1 | $1.75M | Buy |
|
|||||
|
2021
Q4 | $2.58M | Sell |
|
|||||
|
2021
Q3 | $4.46M | Buy |
|
|||||
|
2021
Q2 | $6.13M | Buy |
|
|||||
|
2021
Q1 | $3.71M | Buy |
|
|||||
|
2020
Q4 | $624K | Hold |
|
|||||
|
2020
Q3 | $602K | Buy |
|
|||||
|
2020
Q2 | – | Hold |
|
|||||
|
2020
Q1 | – | Hold |
|
|||||
|
2019
Q4 | – | Hold |
|
|||||
|
2019
Q3 | – | Hold |
|
|||||
|
2019
Q2 | – | Hold |
|
|||||
|
2019
Q1 | – | Hold |
|
|||||
|
2018
Q4 | – | Hold |
|
|||||
|
2018
Q3 | – | Hold |
|
|||||
|
2018
Q2 | – | Hold |
|
|||||
|
2017
Q2 | – | Hold |
|
|||||
|
2017
Q1 | – | Hold |
|
|||||
|
2016
Q4 | – | Hold |
|
|||||
|
2016
Q3 | – | Hold |
|
|||||
|
2016
Q2 | – | Hold |
|
|||||
|
2016
Q1 | – | Hold |
|
|||||
|
2015
Q4 | – | Hold |
|
|||||
|
2015
Q3 | – | Hold |
|